抗NAE抗体阳性桥本脑病临床似多系统萎缩:免疫治疗后123I-碘氟烷结合改善
本文报告1例84岁男性抗α-烯醇化酶N端(NH2末端)抗体阳性桥本脑病患者,临床表现似多系统萎缩,于免疫治疗前后分别行多巴胺转运体SPECT。治疗前多巴胺转运体SPECT示纹状体123I-碘氟烷结合减低,平均特异性结合比为2.42,尽管患者无明显帕金森综合征;免疫治疗后平均特异性结合比改善至3.22。作者认为多巴胺转运体SPECT有助于检出亚临床纹状体功能障碍,治疗前后对比评估有助于区分神经变性疾病与神经免疫性疾病。
要点
- 抗NAE抗体阳性桥本脑病可临床似多系统萎缩,本例无 apparent 帕金森综合征。
- 免疫治疗前多巴胺转运体SPECT示纹状体123I-碘氟烷结合减低,平均特异性结合比为2.42。
- 免疫治疗后平均特异性结合比改善至3.22,治疗前后评估有助于鉴别神经变性与神经免疫性疾病。
核心结论
- 作者认为多巴胺转运体SPECT在本例中有助于检出亚临床纹状体功能障碍,免疫治疗前后的评估有助于区分神经变性疾病与神经免疫性疾病。
研究设计与样本
- 本文为1例84岁男性抗α-烯醇化酶N端(NH2末端)抗体阳性桥本脑病患者的病例报告,该患者临床似多系统萎缩,于免疫治疗前后接受多巴胺转运体SPECT检查。
主要发现
- 免疫治疗前多巴胺转运体SPECT示纹状体123I-碘氟烷结合减低,平均特异性结合比为2.42,当时患者无明显帕金森综合征。
- 免疫治疗后平均特异性结合比改善至3.22。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We describe an 84-year-old man with anti-NH2-terminal of α-enolase antibody-positive Hashimoto encephalopathy that clinically mimicked multiple system atrophy who underwent investigation by dopamine transporter SPECT before and after immunotherapy. Before treatment, dopamine transporter SPECT showed reduced striatal I-ioflupane binding, with a mean specific binding ratio of 2.42, even though he had no apparent parkinsonism. After immunotherapy, mean specific binding ratio was improved to 3.22. Dopamine transporter SPECT was useful in this case to detect subclinical striatal dysfunction, and evaluation both before and after immunotherapy helped to distinguish between neurodegenerative disease and neuroimmunological disorder.
引用
- Otsuka J, Hida A, Ogyu K, et al. Improved 123I-Ioflupane Binding After Immunotherapy in Anti-NAE Antibody-Positive Hashimoto Encephalopathy That Clinically Mimicked Multiple System Atrophy. Clin Nucl Med. 2017. PMID: 28632692. doi:10.1097/RLU.0000000000001728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。